Longeveron Inc. (LGVN)
NASDAQ: LGVN · IEX Real-Time Price · USD
3.155
-0.135 (-4.10%)
Jul 22, 2024, 9:36 AM EDT - Market open
Longeveron Employees
As of December 31, 2023, Longeveron had 24 total employees, including 23 full-time and 1 part-time employees. The number of employees increased by 3 or 14.29% compared to the previous year.
Employees
24
Change (1Y)
3
Growth (1Y)
14.29%
Revenue / Employee
$40,750
Profits / Employee
-$900,917
Market Cap
31.30M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 24 | 3 | 14.29% |
| Dec 31, 2022 | 21 | 1 | 5.00% |
| Dec 31, 2021 | 20 | 8 | 66.67% |
| Dec 31, 2020 | 12 | -4 | -25.00% |
| Dec 31, 2019 | 16 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Cutera | 430 |
| IRIDEX | 111 |
| ReWalk Robotics | 108 |
| ImmuCell | 79 |
| NKGen Biotech | 63 |
| Equillium | 44 |
| Quince Therapeutics | 32 |
| Reviva Pharmaceuticals Holdings | 15 |
LGVN News
- 2 days ago - Longeveron Announces Closing of $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 4 days ago - Longeveron Announces $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 11 days ago - Longeveron stock opened 100% up on Wednesday: explore why - Invezz
- 12 days ago - Longeveron® Announces U.S. FDA Grants Lomecel-B™ Regenerative Medicine Advanced Therapy (RMAT) Designation for the Treatment of Mild Alzheimer's Disease - GlobeNewsWire
- 13 days ago - Neha Motwani Elected to Longeveron® Board of Directors - GlobeNewsWire
- 14 days ago - Gene Therapy Pioneer Roger Hajjar, MD, Elected to Longeveron® Board of Directors - GlobeNewsWire
- 4 weeks ago - Longeveron Raises $4.4 Million in Gross Proceeds from Warrant Exercise Transaction - GlobeNewsWire
- 5 weeks ago - Longeveron® to Present at the Virtual Life Sciences Investor Forum on June 20, 2024 - GlobeNewsWire